共 50 条
- [21] Phase I trial of nab-paclitaxel (A), cisplatin (P) and 5-fluorouracil (F) induction chemotherapy (IC) followed by concurrent chemoradiotherapy (CCRT) in patients (pts) with locoregionally advanced squamous cell carcinoma of head and neck (LA-SCCHN): final results EUROPEAN JOURNAL OF CANCER, 2013, 49 : S749 - S749
- [23] Safety and efficacy of docetaxel combined with cisplatin as induction chemotherapy followed by cisplatin concurrent chemoradiotherapy plus gemcitabine as adjuvant chemotherapy in locally advanced nasopharyngeal carcinoma: A prospective and multicenter phase II trial. JOURNAL OF CLINICAL ONCOLOGY, 2019, 37 (15)
- [26] Randomized Phase II Trial of Gemcitabine and Cisplatin (GP) versus Docetaxel and Cisplatin (TP) as Induction Chemotherapy followed by Concurrent Chemoradiotherapy in Locoregionally Advanced Nasopharyngeal Carcinoma INTERNATIONAL JOURNAL OF RADIATION ONCOLOGY BIOLOGY PHYSICS, 2020, 108 (03): : S106 - S106